- Visibility 266 Views
- Downloads 241 Downloads
- Permissions
- DOI 10.18231/j.ijnmhs.2025.012
-
CrossMark
The association between obesity, dyslipidaemia, and pre-diabetes: Insights from current evidence
- Author Details:
-
Vijaylaxmi Abhijeet Shende *
-
Rita S Mishra
Vijaylaxmi Abhijeet Shende *
Background: This study examines the relationship between obesity, dyslipidemia, and pre-diabetes in a large Indian population. It also assesses the potential of triglycerides (TG) as an early biomarker for pre-diabetes and looks at gender-based differences, especially in younger males.
Materials and Methods: Between October 2022 and July 2023, a cross-sectional, quantitative investigation was carried out at a clinical diagnostic centre in India. Based on glyceated haemoglobin (HbA1c) levels (5.7%–6.4%), 404 people with pre-diabetes and 336 non-diabetic controls were identified among 5,687 screened adults (?18 years). Chi-square and independent t-tests were used to examine the demographic, body mass index (BMI), waist circumference (WC), and lipid profile data.
Results: The prevalence of pre-diabetes was 7.1%. A substantial relationship was found between increased BMI and pre-diabetes, with the majority of those affected being overweight or obese. Central obesity, as measured by waist circumference, was also strongly associated with pre-diabetes. Although a gender-wise subgroup analysis revealed a higher incidence of pre-diabetes among younger males (<40 xss=removed xss=removed xss=removed xss=removed>
Conclusion: Obesity and increased LDL-C levels emerge as important predictors of pre-diabetes. Early detection and focused therapies are critical, especially in people with obesity and lipid problems. Additional large-scale investigations are needed to validate these findings and investigate the function of TG in pre-diabetes progression.
Keywords: Obesity, Dyslipidemia, Pre-diabetes, Metabolic syndrome, Insulin resistance
References
- Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):487–97.
- Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73–81.
- Demir S, Nawroth PP, Herzig S, Üstünel BE. Emerging targets in type 2 diabetes and diabetic complications. Adv Sci (Weinh). 2021;8(18):e2100275.
- White MG, Shaw JAM, Taylor R. Type 2 diabetes: the pathologic basis of reversible β-cell dysfunction. Diabetes Care. 2016;39(11):2080–8.
- World Health Organization. Diabetes[Internet]. Geneva: WHO; 2024 [cited 2024 Nov 14]. Available from: https://www.who.int/en/news- room/fact-sheets/detail/diabetes
- Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol 2021;69(11):2932–8.
- Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5(8):585–6.
- El-Kebbi IM, Bidikian NH, Hneiny L, Nasrallah MP. Epidemiology of type 2 diabetes in the Middle East and North Africa: challenges and call for action. World J Diabetes. 2021;12(9):1401–25
- Schlesinger S, Neuenschwander M, Barbaresko J, Lang A, Maalmi H, Rathmann W, et al. Prediabetes and risk of mortality, diabetes- related complications, and comorbidities: umbrella review of meta- analyses of prospective studies. Diabetologia. 2022;65(2):275–85.
- Hosseini SA, Beiranvand S, Zarea K, Noemani K. Demographic variables, anthropometric indices, sleep quality, Metabolic Equivalent Task (MET), and developing diabetes in the southwest of Iran. Front Public Health. 2023;11:1020112
- de Ritter R, Sep SJS, van der Kallen CJH, van Greevenbroek MMJ, Jong MD, Vos RC, et al. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: the Maastricht Study. Cardiovasc Diabetol.2021;20(1):102.
- ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes 2023. Diabetes care.2023;46(1),S19–
- NHS Inform. Body mass index (BMI) | NHS Inform [Internet]. 2024 Jul 12 [cited 2024 Feb 17].Available from: https://www.nhsinform.scot/healthy-living/food-and- nutrition/healthy-eating-and-weight-management/body-mass-index- bmi/.
- World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation [Internet]. Geneva: WHO; 2008 [cited 2024 Feb 17]. Available from: Shende nad Mishra/ IP Journal of Nutrition, Metabolism and Health Science 2025;8(2):54–59 59 https://iris.who.int/bitstream/handle/10665/44583/9789241501491_ eng.pdf
- Piri Z, Barzin M, Mahdavi M, Guity K, Azizi F, Hosseinpanah F, et al. The role of childhood BMI in predicting early adulthood dysglycemia: Tehran lipid and glucose study. Nutr Metab Cardiovasc Dis. 2020;30(2):313–19
- Bahadoran Z, Mirmiran P, Azizi F, Hosseinpanah F. The association of body weight change and regression to normoglycemia in different phenotypes of pre-diabetes: findings of a longitudinal cohort study. Clin Nutr ESPEN. 2024:63:887–92.
- Johnson ML, Preston JD, Rashid CS, Pearson KJ, Ham JN. Sex differences in type 2 diabetes: an opportunity for personalized medicine. Biol Sex Differ. 2023;14(1):88.
- Shahwan MJ, Jairoun AA, Farajallah A, Shanabli S. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes. Diabetes Metab Syndr. 2019;13(4):2387–92.
- Kuang M, Peng N, Qiu J, Zhong Y, Zou Y, Sheng G. Association of LDL: HDL ratio with prediabetes risk: a longitudinal observational study based on Chinese adults. Lipids Health Dis.2022;21(1):44.
- Alshuweishi Y, Almufarrih AA, Abudawood A, Alfayez D, Alkhowaiter AY, AlSudais H, et al. Patterns of lipid abnormalities in obesity: a comparative analysis in normoglycemic and prediabetic obese individuals. J Pers Med. 2024;14(9):980.
- Kane JP, Pullinger CR, Goldfine ID, Malloy MJ. Dyslipidemia and diabetes mellitus: role of lipoproteins and statins in cardiovascular risk reduction. Curr Opin Pharmacol. 2021:61:21–7.
- Jiang C, Yang R, Kuang M, Yu M, Zhong M, Zou Y. Triglyceride glucose-body mass index in identifying high-risk groups of pre- diabetes. Lipids Health Dis.2021;20:1–12.
- Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients.2013;5(4):1218–40.
- Monnier L, Schlienger JL, Colette C. Updated management of dyslipidemia in diabetes: a new step towards more stringent targets. Diabetes Epidemiol Manag. 2021;1(1):100001.